Synthesis of Highly Borylated 2‑Boraindanes through Multiple Borylation of Diynes.

Yuki Nagashima, Mone Suzuki, Takahiro Komaki, Antônio Junio Araujo Dias, Ken Tanaka, Masanobu Uchiyama

Abstract read

In one paragraph

Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuki NagashimaGraduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-0033, Japan.ORCID https://orcid.org/0000-0001-8470-5638

Mone SuzukiDepartment of Chemical Science and Engineering, Institute of Science Tokyo, O-Okayama, Meguro-Ku, Tokyo 152-8550, Japan.

Takahiro KomakiDepartment of Chemical Science and Engineering, Institute of Science Tokyo, O-Okayama, Meguro-Ku, Tokyo 152-8550, Japan.

Antônio Junio Araujo DiasDepartment of Chemical Science and Engineering, Institute of Science Tokyo, O-Okayama, Meguro-Ku, Tokyo 152-8550, Japan.

Ken TanakaDepartment of Chemical Science and Engineering, Institute of Science Tokyo, O-Okayama, Meguro-Ku, Tokyo 152-8550, Japan.ORCID https://orcid.org/0000-0003-0534-7559

Masanobu UchiyamaGraduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-0033, Japan.ORCID https://orcid.org/0000-0001-6385-5944

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Boraindanes, composed of aromatic two-dimensional (2D) benzene and saturated three-dimensional (3D) boracycle moieties, are considered promising candidates for bioactive compounds/probes, agents for boron neutron capture therapy, and functional materials, as they combine the photophysical properties of the 2D aromatic and the high molecular recognition ability of the 3D boracycle. However, 2-boraindanes are difficult to access due to the difficulty of constructing two unstable C-(sp

Indexed as

boraindaneborate complexDFT calculationfluorescence probemultiple borylation

Identifiers

PMID41614200

DOI10.1021/jacsau.5c01277

PMCPMC12848701

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.